Fundz

Who to call at Recursion Pharmaceuticals, and when

Fundz watches for the moments Recursion Pharmaceuticals starts buying, and tells you who to reach.

  • An alert the day Recursion Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Recursion Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Recursion Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Recursion and Exscientia Partner to Create Trans-Atlantic AI Powerhouse for Drug Development

Nov 21, 2024

Contract Type

partnership

Salt Lake CityBiotechnologyHealthcareHealth CareArtificial IntelligenceTherapeuticsPharmaceutical

Description

Recursion and Exscientia have completed a business combination to enhance their ability to carry out drug discovery that is both first-in-class and best-in-class. The deal includes a pipeline of more than 10 clinical and preclinical programs, 10 programs in advanced discovery phases, and more than 10 additional programs partnered with biopharmas, with a focus on oncology and rare diseases.

Quick answer

Recursion and Exscientia Partner to Create Trans-Atlantic AI Powerhouse for Drug Development (November 21, 2024). Recursion Pharmaceuticals is based in Salt Lake City, Utah, United States.

What agreement did Recursion Pharmaceuticals announce on November 21, 2024?
Recursion and Exscientia have completed a business combination to enhance their ability to carry out drug discovery that is both first-in-class and best-in-class. The deal includes a pipeline of more than 10 clinical and preclinical programs, 10 programs in advanced discovery phases, and more than 10 additional programs partnered with biopharmas, with a focus on oncology and rare diseases.
What does Recursion Pharmaceuticals do?
Recursion Pharmaceuticals, Inc. is a biotechnology company that leverages advanced technology to discover and develop potential new drugs.
Where is Recursion Pharmaceuticals based?
Recursion Pharmaceuticals is based in Salt Lake City, Utah, United States.

Source: Fundz verified event record.

Company Information

Company

Recursion Pharmaceuticals

Location

41S Rio Grande Street

Salt Lake City, Utah, United States

About

Recursion Pharmaceuticals, Inc. is a biotechnology company that leverages advanced technology to discover and develop potential new drugs. The company focuses on therapeutics in disease areas with significant unmet medical need. Through its innovative platform, Recursion aims to transform the process of drug discovery. With a commitment to improving patient outcomes, the company is at the forefront of using data-driven approaches in medicine.

Related People

Najat
Likely contact at this company
••••••••@••••••••

See Najat's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Recursion Pharmaceuticals's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Recursion Pharmaceuticals signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.